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Developmental Toxicity of Ethylene Glycol
Monopropyl Ether Acetate (EGPEA) in the Rat
by Walter J. Krasavage* and Gary V. Katz*
Pregnant rats were exposed by inhalation to vapor concentrations of100, 200, 400 or 800 ppm ofethylene
glycol monopropyl ether acetate on days 6 through 15 of gestation. Concentrations of 400 and 800 ppm
reduced the feed intake, mean body weight and red blood cell counts. Mean corpuscular volume and mean
corpuscular hemoglobin were increased. Clinical signs of toxicity included lethargy and red discolored
urine in the dams exposed to 400 or 800 ppm. The incidence ofresorptions was significantly increased and
the mean fetal body weight was reduced in litters of dams exposed to 800 ppm. Reproductive indices were
not affected. Examinations at cesarean section revealed no major external malformations. Internal soft
tissue examinations revealed three fetuses with a cardiovascular defect consisting of a right-sided aortic
arch. Two of these fetuses were from dams exposed to 800 ppm, while the third was from a control litter.
Skeletal examinations revealed no major skeletal malformations, while minor rib anomalies were slightly
increased in litters from dams exposed to 400 or 800 ppm ofethylene glycol monopropyl ether acetate. The
incidence of common skeletal variants was slightly increased at 200 ppm.
Introduction
Several glycol ethers and their acetates have been
shown to produce reproductive effects by various routes
of exposure in a number of species of experimental
animals. Ethylene glycol monomethyl ether produces
testicular atrophy, fetotoxicity andteratogenic effects in
rats, mice and rabbits (1-8). Ethylene glycol monoethyl
ether has been reported to produce teratogenic and
embryo/fetotoxic effects in rats and rabbits and testic-
ular changes in rats and mice (1,7,9,11-13). Ethylene
glycol monomethyl ether acetate and ethylene glycol
monoethyl ether acetate produce testicular atrophy in
mice (7), while ethylene glycol monoethyl ether acetate
has also been reported to be teratogenic in rats and
rabbits (8,14). Ethylene glycol monopropyl ether given
orally in repeated doses of 1/2, 1/4, or 1/8 the acute oral
LD50 (LD50 = 3089 mg/kg) over a 6-week period did not
produce testicular effects in male rats, while its ester,
ethylene glycol monopropyl ether acetate (LD50 = 9450
mg/kg), given under the same conditions produced 80%
mortality and testicular atrophy at 4400 mg/kg and
testicular changes in 2 of 10 rats at 2200 mg/kg (1,10).
The objective of this study was to evaluate the
potential embryo/fetotoxicity of ethylene glycol mono-
propyl ether acetate in pregnant rats exposed by
inhalation during the period of organogenesis.
*Health and Environment Laboratories, Eastman Kodak Company,
Rochester, NY 14650.
Materials and Methods
Test Compound
Ethylene glycol monopropyl ether acetate (EGPEA)
was obtained from the Tennessee Eastman Company,
Kingsport, TN. Pertinent physical-chemical properties
are: structural formula, C3H7OCH2CH200CCH3; mo-
lecular weight, 146.21; boiling point, 170-171°C; melt-
ing point, < -45°C; specific gravity, 0.93; vapor pres-
sure, 0.5 mm Hg at 25°C; flash point: 142°F
The purity of the batch tested was analyzed by gas
chromatography and mass spectroscopy and found to be
99.6% pure. The main impurity was ethylene glycol
monopropyl ether. Otherpossible impurities were acetic
acid, propyl acetate, hexyl acetate, ethylene glycol
monobutyl ether acetate and ethylene glycol monoethyl
ether acetate (50-100 ppm).
Test Animals
Sexually mature male and female rats (COBS CD
(SD)BR)fromtheCharlesRiverBreedingLaboratories,
Wilmington, MA, were acclimated to the laboratory for
2weeks priortomating. Males and females were housed
1:2 over a 9-day period to obtain 120 inseminated
females. Insemination was verified by daily vaginal
smears and the day sperm was found in the vagina was
designated day 0 ofgestation. The inseminated females
were assigned to the treatment and control groupsKRASAVAGE AND KATZ
according to day 0 of gestation using a computer-
generated stratified randomization scheme.
Duringnonexposure periods, thefemaleswerehoused
singly in suspended stainless steel wire bottom cages
and Purina Rodent Laboratory Chow 5001 (ground) and
tap water, delivered by an automatic watering system,
were available ad libitum. Room temperature and
relative humidity were controlled at 22 + 2°C and 50 +
15%, respectively, and a 12-hr light-dark photocycle
was maintained.
Exposure Conditions
On days 6 through 15 of gestation, the animals were
housed in a suspended wire cage and exposed to vapors
of ethylene glycol monopropyl ether acetate in 420-L
stainless steel and glass inhalation chambers.
Vapors of ethylene glycol monopropyl ether acetate
were generated by passing metered air over the surface
of the liquid in a three-necked, round-bottomed flask.
Temperature in the flask was slightly elevated (up to
40°C) to aid vaporization. The atmospheres within the
chambers were sampled at least once per hour for
concentration, temperature and relative humidity. Con-
centrations were quantitatively analyzed by using an
infrared analyzer (Miran IA) which had been automated
for sampling and analysis. Nominal concentrations were
calculated daily based on the ratio oftest material used
(volumetric) to total volume ofair. Airborne particulate
counts were measured twice daily in each chamber by
using a Royco five-channel particle analyzer. The ani-
mals were rotated daily within the chamber to minimize
potential positional effects.
Experimental Design
Groups of 24 inseminated females were exposed to
vapor concentrations of 100, 200, 400 or 800 ppm of
ethylene glycol monopropyl ether acetate for6 hr/day on
days 6through 15 ofgestation. The exposure concentra-
tions were selected based on data generated in a probe
teratology study of ethylene glycol monopropyl ether
acetate (15). A control group was exposed to filtered air
under identical conditions.
Maternal body weights were recorded on days 0, 6, 9,
12, 16 and 19 ofgestation, and individual feed consump-
tion was measured on days 6, 9, 12, 16 and 19 of
gestation. On days ofexposure, all dams were observed
for mortality and overt signs of toxicity prior to and
subsequent to each exposure. Animals visible through
the chamber windows were observed for signs of
toxicity during exposure. On nonexposure days all
females were observed twice daily for mortality and
overt signs oftoxicity, except on weekends and holidays,
when they were observed for mortality only.
On day 20 of gestation, the dams were anesthetized
by CO2 inhalation, and the abdominal viscera were
exposed by a midline incision through the abdominal
wall. Ten dams, randomly selected from each group,
were bled from the inferior vena cava for hematologic
determinations including total red blood cell and white
blood cell counts, hemoglobin concentration, and hema-
tocrit. Mean corpuscular volume, mean corpuscular
hemoglobin and mean corpuscular hemoglobin concen-
tration were calculated. All animals were fasted for 10
to 12 hr before bleeding. After exsanguination via the
vena cava, the dams were weighed and the uterine
hornswere opened. The implantation sites werecounted
and categorized as viable or dead fetuses, early resorp-
tions or late resorptions. A resorption was classified as
"early" when no placenta or conceptus was distin-
guishable and as "late" when a placenta containing an
embryo in the process of being resorbed (partially to
fully formed) was present. The viable fetuses were
removed from the placenta, blotted dry on absorbent
paper, sexed, examined for gross external abnor-
malities, and weighed individually. The ovaries were
removed, identified as left or right, and the corpora
lutea of pregnancy were counted. Approximately one-
half of the fetuses from each litter was fixed in Bouin's
solution and examined for internal soft tissue anomalies
using Wilson's free-hand razor blade technique (16).
The other half of the fetuses was fixed in 95% ethanol,
macerated with potassium hydroxide and stained with
Alizarin Red S and examined for skeletal defects (17).
The thoracic and abdominal viscera of the dams were
examined in situ for gross abnormalities at the time of
cesarean section.
Statistical Analyses
Test groups were compared to the control group at a
level of significance of p
- 0.05. Continuous data
(e.g., maternal body weight, feed consumption, hema-
tology) were analyzed using a one-way analysis of
variance with significant F values further analyzed by
Duncan's Multiple Range test. Homogeneity of vari-
ances was tested by Bartlett's test. Incidence data were
compared by using chi-square contingency tables (2 x
5). Each test group was compared to the control group
using Fisher's exact test (one-tailed) when chi square
was significant. Resorptions per litter were analyzed by
ANOVA after a Freeman-Tukey transformation. Both
the proportion of fetuses affected and the number of
litters involved were analyzed.
Results
Exposure Conditions
The analytical and nominal chamber concentrations,
chamber temperature and relative humidity are shown
in Table 1. The overall mean analytical concentrations
(ofall individual determinations) of95, 203, 393 and 822
ppm were all within ± 5% of the target concentrations
of 100, 200, 400 and 800 ppm, respectively. The indi-
vidual daily means (not shown) of each exposure level
were within ± 15% of their respective target concen-
trations. Except for the mean nominal concentration at
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Table 1. Ethylene glycol monopropyl ether acetate inhalation teratology: summary of exposure conditions.
Target concn
0 100 ppm 200 ppm 400 ppm 800 ppm
Number of exposures 10 10 10 10 10
Analyzed concentration, ppm
Overall mean + SD 0.0 95 ± 8 203 ± 11 393 ± 22 822 ± 44
Extremes of daily means - 85-105 184-222 371-432 750-876
Nominal concentration + SD, ppma 89 ± 8 292 ± 12 466 ± 43 1232 ± 205
Overall mean temperature ± SD, 'C 22 + 1 22 ± 1 22 ± 1 21 + 1 21 ± 1
Overall mean relative humidity ± SD, % 53 ± 4 63 ± 7 52 ± 5 51 ± 7 42 ± 5
aCalculated daily from volume of chemical used and total airflow.
Table 2. Ethylene glycol monopropyl ether acetate-inhalation teratology: maternal body weight.
Target conen
0 100 ppm 200 ppm 400 ppm 800 ppm
Mortality/pregnant
female 0/21 0/21 0/20 0/23 0/21
Maternal weight (g) on
various gestation days
0 248 ± 12a 254 ± 16 258 ± 16 248 ± 14 254 ± 19
6 276 ± 15 283 ± 19 282 ± 17 273 ± 17 281 ± 21
9 286 ± 15 292 ± 17 289 ± 18 272 ± 19* 254 ± 23*
12 301 ± 12 303 ± 18 302 ± 18 283 ± 20* 274 ± 22*
16 321 ± 15 324 ± 22 324 21 309 ± 21* 299 ± 27*
19 360 ± 23 364 ± 31 370 28 359 ± 25 344 ± 33
aMean ± 1 standard deviation.
*Statistically significant compared to control (ANOVA p < 0.05).
Table 3. Ethylene glycol monopropyl ether acetate-inhalation teratology: maternal feed consumption.
Target conen
0 100 ppm 200 ppm 400 ppm 800 ppm
Mortality/pregnant
female 0/21 0/21 0/20 0/23 0/21
Maternal feed
consumption during
gestation days,
g/rat/daya
0-6 19.1 ± 2.0a 20.2 ± 2.2 19.6 ± 4.5 18.7 ± 2.4 19.1 ± 2.6
6-9 19.6 ± 1.9 20.1 ± 2.4 18.5 ± 3.2 14.1 ± 3.1* 5.7 ± 3.5*
9-12 22.3 ± 1.8 22.3 ± 2.1 22.1 ± 2.6 20.3 ± 3.0* 17.2 + 3.1
12-16 29.3 ± 6.7 29.6 ± 5.8 31.7 ± 6.2 28.3 ± 7.1 27.8 ± 6.3
16-19 27.4 ± 3.4 28.4 ± 4.1 29.3 ± 2.5 30.1 ± 2.8* 31.7 ± 4.0*
aMean ± 1 standard deviation.
*Statistically significant compared to control (ANOVA p < 0.05).
the lowest level which was slightly less than the
analytical concentration, all mean nominal concentra-
tions were slightly higher than their respective analyt-
ical concentrations. These differences probably reflect
a loss of the compound in the generation system.
The analytical data indicate that the chamber con-
centrations were representative of the chosen target
concentrations.
Maternal Observations
Body Weight Response and Feed Consumption.
Mean body weights of the dams exposed to 400 and 800
ppm of ethylene glycol monopropyl ether acetate were
significantly (p
- 0.05) lower than the control weights
on days 9, 12 and 16 of gestation (Table 2). During the
first 3 days of exposure, 400 and 800 ppm produced a
body weight loss which at the 800 ppm level was equal
to 10.9% ofthe mean body weight ofthis group. During
the following 3 days (9-12 of gestation) the 400 ppm
animals gained significantly less weight than the con-
trols, while the 800 ppm rats gained significantly
more weight. Weight gain in these two groups was
comparable to or greater than the controls between
days 12 and 19 ofgestation. Thus, 4 days after termina-
tion of exposure, the mean body weight of the 400 ppm
animals was comparable to the controls and the mean
body weight of the 800 ppm animals, though not
statistically different, was slightly less (4.4%) than the
control weight. Exposures to 100 and 200 ppm of
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ethylene glycol monopropyl ether acetate had no effect
on body weight gain.
Exposure to 400 and 800 ppm of EGPEA produced a
significant (p
- 0.05) reduction in feed intake between
days 6 and 12 of gestation (Table 3). Feed intake was
severely reduced between day 6 and 9 in the 800 ppm
group, causing a severe loss of body weight in these
dams. From day 12 to 19 ofgestation, 400 and 800 ppm
had no effect on feed consumption, and the intake of
these two groups were comparable to or greater than
the control intake during this time. Feed consumption
was not affected by exposures of 100 or 200 ppm of
EGPEA.-
Clinical Signs. Significant clinical signs of toxicity
duringexposure were slightlethargy inthe ratsexposed
to 800 ppm; seen also to a lesser degree in the 400 ppm
animals. Red-discolored urine (positive for hemoglobin
in a N-Multistix-C test) was found on the dropping trays
of 16 of 24 animals exposed to 800 ppm and 1 of 24
animals exposed to 400 ppm after the first exposure. It
was also seen in 2 of 24 animals after two exposures to
800 ppm. It was not seen after subsequent exposures
norwas it seen at anytime in the controls or the animals
exposed to 100 or 200 ppm.
Hematology. Exposure to 400 or 800 ppm EGPEA
produced a statistically significant reduction in total red
blood cells (Table 4). Mean corpuscular volume and
mean corpuscular hemoglobin were increased at these
concentrations; 800 ppm also increased the mean
corpuscular hemoglobin concentration. The mean cor-
puscular volume was also slightly increased in the
animals exposed to 200 ppm ofEGPEA. However, none
of the other hematologic parameters were affected by
this level of exposure, thus this increase in MCV is not
considered biologically significant. None of the expo-
sureconcentrationsaffectedhemoglobinconcentrations,
hematocrit or the total white blood cell count.
Gross Pathology. At the time of cesarean section,
one dam exposed to 800 ppm had an enlarged liver with
rounded edges and the spleen was enlarged. These
findings were probably compound related, but were
seen only in one animal. Another dam, exposed to 100
Table 4. Ethylene glycol monopropyl ether acetate-inhalation teratology: maternal hematology.
Target concn
0 100 ppm 200 ppm 400 ppm 800 ppm
White blood cells/mm3 x 103a 8.7 ± 1.6 9.3 ± 1.9 8.0 ± 1.4 8.2 ± 1.5 8.4 ± 1.8
Red blood cells/mm3 x 106a 6.4 ± 0.8 6.1 ± 0.6 6.1 ± 1.0 5.2 ± 0.3 5.2 ± 0.5*
Hemoglobin concentration, g/dLa 12.8 ± 1.4 12.2 ± 1.1 12.3 ± 1.8 11.7 ± 0.5 13.1 ± 1.2
Hematocrit, %V 39.3 ± 4.8 37.6 ± 3.8 38.2 ± 6.4 35.3 ± 1.9 38.0 ± 3.3
Mean corpuscular volume, p.m3a 60.8 + 1.1 61.1 ± 2.2 62.9 ± 1.5 67.3 ± 2.2* 72.3 ± 1.6*
Mean corpuscular hemoglobin, pga 19.9 ± 0.4 19.9 ± 0.7 20.3 ± 0.7 22.4 ± 0.9* 25.0 ± 1.2*
Mean corpuscular hemoglobin
concentration, %a 32.6 ± 0.5 32.5 ± 0.9 32.4 ± 0.7 33.2 ± 0.6 34.5 ± 1.1*
aMean ± 1 standard deviation (n = 10).
*Statistically significant compared to controls (ANOVA p S 0.05).
Table 5. Ethylene glycol monopropyl ether acetate inhalation teratology: summary of observations at time of cesarean sections.
Target concn
0 100 ppm 200 ppm 400 ppm 800 ppm
Number of females inseminated 24 24 24 24 24
Number of females pregnant (%) 21(88) 21(88) 20(83) 23(96) 21(88)
Number litters completely resorbed 0 0 0 0 1
Number litters with resorptions 13 6 12 11 16
Corpora lutea per dama 14.9 ± 3.3 15.0 ± 3.8 16.1 ± 3.7 14.4 ± 2.4 15.4 ± 3.8
Implantations per dama 12.4 ± 4.2 12.1 ± 4.5 13.4 ± 4.0 14.1 ± 2.8 14.4 ± 2.1
Viable fetuses per littera 11.4 ± 4.2 11.5 ± 4.6 12.7 ± 3.8 13.5 ± 2.8 10.4 ± 4.8
Resorptions per littera 0.95 + 0.97 0.62 ± 1.2 0.70 ± 0.66 0.61 ± 0.72 4.00 ± 4.7
Resorptions per litter with resorptionsa 1.5 ± 0.8 2.2 ± 1.3 1.2 ± 0.4 1.3 ± 0.5 5.3± 4.7±
Dead fetuses per litter 0 0 0 0 0
Pre-implantation loss, %b 16.9 19.6 16.8 2.4 6.2
Post-implantation loss, %C 7.7 5.2 5.2 4.3 27.7
Sex ratio (M:F) 49:51 53:47 45:55 54:46 53:47
Fetal body weight, ga 3.37 ± 0.29 3.52 ± 0.31 3.19 ± 0.31 3.26 ± 0.22 2.57 ± 0.30
aMean ± 1 standard deviation.
b% Pre-implantation loss =
C% Post-implantation loss =
(number of corpora lutea - number of implantations) x 100
number of corpora lutea.
(number of implantations - number of viable implantations) x 100
Number of implantations.
*Statistically significant compared to controls (ANOVA p S 0.05).
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ppm, had enlarged lymph nodes in the lower left
inguinal region beneath the nipple of the mammary
gland. This finding was noted only in one animal and
was not seen at the higher concentrations thus it is not
considered to be compound related.
Observations at the Time of Cesarean Sections.
Signs of embryo/fetolethality and fetotoxicity noted in
the animals exposed to 800 ppm of ethylene glycol
monopropyl ether acetate included a significant increase
in the number of resorptions per litter, indicative of an
increased post-implantation loss, and a significant (p S
0.05) reduction in mean fetal body weight (Table 5). The
lower exposure concentrations did not produce these
effects. The rate of pregnancy, number of corpora lutea,
implantation sites or viable fetuses per dam or the sex
ratio of the fetuses were not affected by any of the
exposure concentrations.
Fetal Observations
External and Internal Soft Tissue Examinations.
Externally, two fetuses, one from each of two 800 ppm
litters were edematous and had a stubby appearance
(Table 6). Other external findings included a severely
atrophied tail on one fetus from a dam exposed to 200
ppm, small hematomas on one fetus each in two litters
exposed to 100 or 800 ppm and a hemorrhagic streak
extending from between the eyes to the nares in one
control fetus and in the occipital region of one fetus in
the 100 ppm group. The eyelids of one fetus from a dam
exposed to 200 ppm appeared somewhat darker than
normal. Except for the edema seen in the 800 ppm
fetuses, none ofthe external findings are considered to
be compound related.
Three of635 fetuses examined for internal soft tissue
anomalies had a major malformation of the cardiovas-
cular system (Table 7). One fetus from a dam exposed to
800 ppm of EGPEA had a ringed aorta, and another
fetus from adifferent litterhad aright-sided aortic arch
with a right-sided ductus arteriosus. One control fetus
had a right-sided aortic arch with a left-sided ductus
arteriosus. One fetus in an 800 ppm litter had dilated
cardiac ventricles. This fetus was one ofthe two fetuses
noted with edema and a stubby body. The dilation ofthe
ventricles was probably related to the edematous
condition. In addition, minor internal soft tissue anoma-
lies including unilateral and/or bilateral hydronephrosis
and hydroureter were seen in all treatment groups and
the controls. Though not statistically significant, the
occurrence of hydronephrosis was found most fre-
quently in the 800 ppm fetuses.
Skeletal Examinations. No major skeletal malfor-
mations were seen in any of the exposed groups (Table
8). Minor skeletal anomalies included wavy and/or
knobby ribs, fused, thickened or shortened (partially
ossified) ribs and beginning sites ofossification (spurs),
either unilateral or bilateral, adjacent to the seventh
cervical vertebrae. Wavy and/orknobbyribs were found
in all groups. Statistically, the proportion of fetuses
with this defect was greater in the 800 ppm group
Table 6. Ethylene glycol monopropyl ether acetate-inhalation teratology: external fetal abnormalities.
Target conen
0 100 ppm 200 ppm 400 ppm 800 ppm
No. of fetuses (litters) examined 240(21) 241(21) 253(20) 310(23) 219(20)
External defectsa
Hematoma 2(2) 1 2(2)
Hemorrhagic streak
Occipital area 1
Between eyes to nares 1
Eyelids dark in appearance 1
Edematous with stubby appearance 2(2)
Tail: severe atrophy 1
aNumber of fetuses affected; litters in parentheses.
Table 7. Ethylene glycol monopropyl ether acetate inhalation teratology: internal soft tissue fetal abnormalities.
Target conen
0 100 ppm 200 ppm 400 ppm 800 ppm
No. of fetuses (litters) examined 121(21) 120(21) 127(20) 157(23) 110(20)
Soft tissue defectsa
Cardiovascular
Right-sided aortic arch, right-sided ductus arteriosus 1
Right-sided aortic arch, left-sided ductus arteriosus 1
Ringed aorta 1
Dilated cardiac ventricles lb
Renal
Hydronephrosis 4(2) 2(2) 5(4) 1 9(5)
Hydroureter 4(1) 3(2) 1 2(2) 5(3)
'Number of fetuses affected; litters in parentheses.
bOne of the fetuses with edema and a stubby body.
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Table 8. Ethylene glycol monopropyl ether acetate inhalation teratology: summary of skeletal alterations.
Target conen
0 100 ppm 200 ppm 400 ppm 800 ppm
No. of fetuses (litters) examined 119(21) 121(21) 126(20) 153(23) 108(19)
Major skeletal malformationsa 0 0 0 0 0
Minor skeletal alterations: ribsa
Spur at 7th cervical vertebra 7(2)
Only 12 pair present 1 3(1)
Wavy/knobby' 5(4) 3(1) 2(2) 10(4) 17*(9)
Partial ossification 4(2) 1 4(2) 1
Fused 1 2(1)
Thickened 2(2)
Tbtal rib defects 7(5) 4(2) 2(2) 12(5) 20(9)*
Alterations indicative of retarded development: skull bones
Partial ossification
Frontals 1 8(4)
Parietals 2(2) 4(2) 11(7)
Occipitals 1 4(2) 23(11)
Hyoid 5(4) 2(2) 3(3) 7(5) 19(8)
Presphenoid 18(9)
Nonossification
Occipitals 2(2)
Hyoid 2(2) 1 12(9) 17(8) 42(16)
Presphenoid 1 1 26(12)
Tbtal skull defectsb 8(5) 3(3) 16(9) 24*(10)* 71*(16)*
Alterations indicative of retarded development: vertebrae
Cervical arches
Partial ossification (4th-7th) 2(1)
Thoracic centra
Partial ossification 10(4) 6(3) 19(10) 20(7) 80(lo)
Nonossification 4(2) 1 56(17)d
Cleft (bilobed) 11(6) 22(9) 17(9) 21(11) 61(17)
Split 3(3) 5(3) 6(4) 2(2) 20(12)
Lumbar arches
Partial ossification 1
Lumbar centra
Partial ossification 3(2)
Fused 1
Cleft (bilobed) 12(9)
Split 1 4(2)
Extra lumbar veretbra 1
Sacral arches and centra
Partial ossification 1 1 20(9)
Nonossification 7(5)
Caudal
None present 1 1 15(9)
Tbtal vertebral defectsb 18(8) 28(14) 34*(12) 40*(14) 98*(19)*
Alterations indicative of retarded development: sternebrae
< 4 Present 6(4) 1 15(8)
Partial ossification 8(5) 4(4) 14(7) 12(8) 51(16)
Nonossification 4(3) 11(6)
Cleft (bilobed) 1 1 5(2)
Split 1
Tbtal sternebral defectsb 13(7) 4(4) 15(8) 14(8) 56*(16)*
Alterations indicative of retarded development: pelvic girdle
Partial ossification
Pubis 1 1 2(1) 1 15(6)
Ilium 1
Ischium 3(2)
Nonossification
Pubis 1 9(5)
Ilium 1 2(1)
Ischium 1 2(2)
Tbtal pelvic girdle defectsb 1 1 3(2) 1 26*(8)*
Alterations indicative of retarded development:
fore and hind limbs
Partial ossification
Metacarpals 1 7(4)
Metatarsals 4(2)
Tbtal limb defectsb 1 8*(4)*
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Table 8. (continued)
Target conen
0 100 ppm 200 ppm 400 ppm 800 ppm
Common skeletal variantsa
Thoracolumbar ribs (14th)
Rudimentary ( < 1/2 13th rib)b 19(8) 24(14) 32*(14)* 48(18)* 71*(19)*
Extra ( > 1/2 13th rib)b 3(2) 5(3) 19(10)*
Total skeletal alterationsb,c 49(17) 53(20) 74*(19) 87*(19) 108*(19)
aNumber of fetuses with specific alteration; number of litters involved in parentheses.
blst, 2nd centra most frequently affected.
CNumber of fetuses (litters) with at least one of the above listed skeletal alterations.
dThese data were analyzed statistically.
*Statistically different from controls p S (0.05) chi-square table and Fisher's exact test (one-tailed).
compared to the controls; however, the number of
litters involved, though on the borderline ofsignificance
(p = 0.058), was not different from the controls. Fused
ribs were seen in one litter each at the 400 and 800 ppm
levels, while thickened ribs were seen in two litters of
the 800 ppm level. Neither ofthese defects were seen in
the control fetuses. The frequency of partially ossified
ribs seen in the treated groups was equal to or less
than in the controls. Cervical spurs were seen only
at the 800 ppm level and were found in seven fetuses
from two litters.
Other skeletal defects noted were those indicative of
delayed ossification and common skeletal variants, i.e.,
partial and/or nonossification of the bones of the skull,
sternebrae, vertebral centra, metacarpals, metatarsals,
and the presence of rudimentary and/or extra ribs.
Statistically significant effects on the process of ossifi-
cation of the skull bones, vertebrae (particularly the
thoracic centra), sternebrae, bones of the pelvic gir-
dle and the metacarpals and metatarsals were pro-
duced by 800 ppm ofEGPEA. A statistically significant
proportion of the fetuses exposed to 400 ppm had
decreased ossification of the skull bones and thoracic
vertebral centra. Effects on the thoracic vertebral
centra were also seen in the 200 ppm group; however,
the number of litters involved at this level and at
the 400 ppm level was not statistically different from
the controls.
Exposure to 200, 400 and 800 ppm produced a
significant increase in rudimentary ribs, while 800 ppm
significantly increased the incidence of extra 14th ribs.
Discussion
Exposure of pregnant rats to 400 and 800 ppm of
ethylene glycol monopropyl ether acetate on days 6
through 15 of gestation produced maternal toxicity,
which was not seen in dams exposed to 100 and 200 ppm
of EGPEA. At 800 ppm, EGPEA produced significant
fetolethality (increased incidence of resorptions) and a
significant reduction of mean fetal body weight.
No major external or skeletal malformations were
found in fetuses from dams exposed to concentrations of
EGPEA as high as 800 ppm. Internal soft tissue
examinations revealed two fetuses, each from different
dams, exposed to 800 ppm of EGPEA and one control
fetus with persistent right aortic arches. Cardiovas-
cular anomalies have been reported to occur spontane-
ously in this strain ofrat, albeit at a very low rate (18).
The occurrence ofthis malformation in a control fetus in
this study and the significant maternal toxicity pro-
duced by 800 ppm of EGPEA indicate that this finding
is probably not a compound-related effect. Minor soft
tissue anomalies were slightly increased in the 800 ppm
group only; while minor skeletal anomalies were signi-
ficantly increased by 800 ppm EGPEA and slightly,
but not statistically, increased by 400 ppm. Thus, 800
ppm of ethylene glycol monopropyl ether acetate was a
no-observed effect level for major skeletal malforma-
tions, while minor skeletal anomalies were seen at a
very low incidence in the 400 ppm group.
Other skeletal changes were those indicative of
delayed ossification and the skeletal variants commonly
seen in teratology studies. These consisted ofpartial or
nonossification of: bones of the skull, vertebral centra,
sternebrae, bones of the pelvic girdle, and the occur-
rence of 14th rudimentary and/or extra thoracolumbar
ribs. The incidences of all of these alterations were
significantly increased by 800 ppm of EGPEA. Delayed
ossification ofthe skull bones was still slightlyincreased
at 400 ppm, while common variants such as delayed
ossification of the first and second thoracic centra and
the occurrence of 14th rudimentary ribs were slightly
increased at 200 ppm.
Conclusions
Vapor concentration of ethylene glycol monopropyl
ether acetate as high as 800 ppm did not produce
teratogenic effects in the rat. Concentrations of800 and
400 ppm, which were overtly toxic to the maternal
animal, produced minor embryo/fetotoxicity indicative
ofretarded development, while 200 ppm ofEGPEA did
not significantly affect development, but did slightly
increase the incidence of common skeletal variants.
EGPEA does appear to have an effect on fetal develop-
ment, but only at high doses which are overtly toxic
to the mother. Thus, if the exposure level of EGPEA
is kept below the levels toxic to the adult, the con-
ceptus should not be affected.
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